Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Liraglutide and Renal Outcomes in Type 2 Diabetes

Johannes F.E. Mann, David D. Ørsted, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody

Charles Pyke, R. Scott Heller, Rikke Kaae Kirk et al. · Endocrinology · 2014 · 834 citations · Full text

Life Sciences, Endocrinology, Pharmacology +15

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

Louise A. Scrocchi, Theodore J. Brown, Neil J. MacLusky et al. · Nature Medicine · 1996 · 795 citations

Medicine, Endocrinology, Genetics +15

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

Minsuk Kim, Mathew J. Platt, Tadao Shibasaki et al. · Nature Medicine · 2013 · 503 citations

Life Sciences, Pharmacology, Physiology +13